secwatch / observer
8-K filed April 29, 2026, 7:59 PM ET ticker VRTX CIK 0000875320
leadership confidence high sentiment neutral materiality 0.30

Vertex director Suketu Upadhyay to depart after annual meeting to become Incyte CFO

VERTEX PHARMACEUTICALS INC / MA

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Suketu Upadhyay

Director
VRTX · VERTEX PHARMACEUTICALS INC / MA
Filed
April 29, 2026, 7:59 PM ET
Suketu Upadhyay informed the board of directors (the "Board") of Vertex Pharmaceuticals Incorporated (the "Company") of his decision not to stand for re-election as a director of the Company at the Company’s 2026 annual meeting of shareholders (the "2026 Annual Meeting").

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Suketu Upadhyay departed as Director at VERTEX PHARMACEUTICALS INC / MA.

Action
not standing for re-election
Role
Director
Exact text from the filing
Suketu Upadhyay informed the board of directors (the "Board") of Vertex Pharmaceuticals Incorporated (the "Company") of his decision not to stand for re-election as a director of the Company at the Company’s 2026 annual meeting of shareholders (the "2026 Annual Meeting").
View on SEC.gov

VERTEX PHARMACEUTICALS INC / MA filing history →

Source: SEC EDGAR
accession 0000875320-26-000166
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.